Luye Pharma Group Stock Retained Earnings
| LYPHF Stock | USD 0.34 0.00 0.00% |
Luye Pharma Group fundamentals help investors to digest information that contributes to Luye Pharma's financial success or failures. It also enables traders to predict the movement of Luye Pink Sheet. The fundamental analysis module provides a way to measure Luye Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Luye Pharma pink sheet.
Luye |
Luye Pharma Group Company Retained Earnings Analysis
Luye Pharma's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
| Competition |
Based on the latest financial disclosure, Luye Pharma Group has a Retained Earnings of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—General (which currently averages 0.0) industry. The retained earnings for all United States stocks is 100.0% higher than that of the company.
Luye Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Luye Pharma's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Luye Pharma could also be used in its relative valuation, which is a method of valuing Luye Pharma by comparing valuation metrics of similar companies.Luye Pharma is currently under evaluation in retained earnings category among its peers.
Luye Fundamentals
| Return On Equity | -0.0261 | |||
| Return On Asset | 0.0081 | |||
| Profit Margin | (0.04) % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 2.08 B | |||
| Shares Outstanding | 3.55 B | |||
| Shares Owned By Insiders | 35.41 % | |||
| Shares Owned By Institutions | 24.08 % | |||
| Price To Book | 2.17 X | |||
| Price To Sales | 0.47 X | |||
| Revenue | 5.2 B | |||
| Gross Profit | 3.4 B | |||
| EBITDA | 324.9 M | |||
| Net Income | (134.39 M) | |||
| Total Debt | 4.21 B | |||
| Debt To Equity | 1.15 % | |||
| Current Ratio | 1.46 X | |||
| Book Value Per Share | 2.54 X | |||
| Cash Flow From Operations | 182.37 M | |||
| Earnings Per Share | 0.03 X | |||
| Number Of Employees | 4.8 K | |||
| Beta | 0.93 | |||
| Market Capitalization | 2.66 B | |||
| Total Asset | 22.58 B | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 22.58 B |
About Luye Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Luye Pharma Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Luye Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Luye Pharma Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Luye Pink Sheet
Luye Pharma financial ratios help investors to determine whether Luye Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Luye with respect to the benefits of owning Luye Pharma security.